Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma (vol 14, pg 561, 2019)

被引：0
|
作者：
Plotkin, S. R.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
10.1200/JCO.20.00060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：656 / 656
页数：1
相关论文
共 50 条
  • [21] Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study
    Dai Maruyama
    Kensei Tobinai
    Michinori Ogura
    Toshiki Uchida
    Kiyohiko Hatake
    Masafumi Taniwaki
    Kiyoshi Ando
    Kunihiro Tsukasaki
    Takashi Ishida
    Naoki Kobayashi
    Kenichi Ishizawa
    Yoichi Tatsumi
    Koji Kato
    Toru Kiguchi
    Takayuki Ikezoe
    Eric Laille
    Tokihiro Ro
    Hiromi Tamakoshi
    Sanae Sakurai
    Tomoko Ohtsu
    International Journal of Hematology, 2017, 106 : 655 - 665
  • [22] Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study
    Maruyama, Dai
    Tobinai, Kensei
    Ogura, Michinori
    Uchida, Toshiki
    Hatake, Kiyohiko
    Taniwaki, Masafumi
    Ando, Kiyoshi
    Tsukasaki, Kunihiro
    Ishida, Takashi
    Kobayashi, Naoki
    Ishizawa, Kenichi
    Tatsumi, Yoichi
    Kato, Koji
    Kiguchi, Toru
    Ikezoe, Takayuki
    Laille, Eric
    Ro, Tokihiro
    Tamakoshi, Hiromi
    Sakurai, Sanae
    Ohtsu, Tomoko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (05) : 655 - 665
  • [23] Phase I/II Multicenter Study of Romidepsin in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Ogura, Michinori
    Maruyama, Dai
    Tobinai, Kensei
    Uchida, Toshiki
    Hatake, Kiyohiko
    Taniwaki, Masafumi
    Ando, Kiyoshi
    Tsukasaki, Kunihiro
    Ishida, Takashi
    Kobayashi, Naoki
    Ishizawa, Kenichi
    Tatsumi, Yoichi
    Kato, Koji
    Kiguchi, Toru
    Ikezoe, Takayuki
    Laille, Eric
    Ro, Tokihiro
    Tamakoshi, Hiromi
    Sakurai, Sanae
    Ohtsu, Tomoko
    BLOOD, 2016, 128 (22)
  • [24] Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma (vol 98, pg 131, 2019)
    Maruyama, Dai
    Tsukasaki, Kunihiro
    Uchida, Toshiki
    Maeda, Yoshinobu
    Shibayama, Hirohiko
    Nagai, Hirokazu
    Kurosawa, Mitsutoshi
    Suehiro, Yoko
    Hatake, Kiyohiko
    Ando, Kiyoshi
    Yoshida, Isao
    Hidaka, Michihiro
    Murayama, Tohru
    Okitsu, Yoko
    Tsukamoto, Norifumi
    Taniwaki, Masafumi
    Suzumiya, Junji
    Tamura, Kazuo
    Yamauchi, Takahiro
    Ueda, Ryuzo
    Tobinai, Kensei
    ANNALS OF HEMATOLOGY, 2018, 97 (12) : 2529 - 2530
  • [25] International Randomized Phase III Study of Elacytarabine Versus Investigator Choice in Patients With Relapsed/Refractory Acute Myeloid Leukemia
    Roboz, Gail J.
    Rosenblat, Todd
    Arellano, Martha
    Gobbi, Marco
    Altman, Jessica K.
    Montesinos, Pau
    O'Connell, Casey
    Solomon, Scott R.
    Pigneux, Arnaud
    Vey, Norbert
    Hills, Robert
    Jacobsen, Tove Flem
    Gianella-Borradori, Athos
    Foss, Oivind
    Vetrhusand, Sylvia
    Giles, Francis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (18) : 1919 - +
  • [26] Mogamulizumab Monotherapy in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma or Cutaneous T-Cell Lymphoma Patients in Single-Institution Experience
    Murai, Kazunori
    Hiroyuki, Hamada
    Sato, Akiyoshi
    Yasuro, Miyairi
    Mori, Yasuki
    Sakuma, Tsutomu
    BLOOD, 2017, 130
  • [27] PHASE 3 STUDY OF PATIENTS WITH RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA: COMPARISON OF TREATMENT WITH TEMSIROLIMUS vs INVESTIGATOR'S CHOICE THERAPY
    Verhoef, E. G.
    He, G.
    Romaguera, J.
    Herbrecht, R.
    Crump, M.
    Strahs, A.
    Hanushevsky, O.
    Binlich, F.
    Hewes, B.
    Coiffier, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 174 - 174
  • [28] A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas
    Boonstra, Philip S.
    Polk, Avery
    Brown, Noah
    Hristov, Alexandra C.
    Bailey, Nathanael G.
    Kaminski, Mark S.
    Phillips, Tycel
    Devata, Sumana
    Mayer, Tera
    Wilcox, Ryan A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (12) : 1287 - 1294
  • [29] A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
    Strati, Paolo
    Chihara, Dai
    Oki, Yasuhiro
    Fayad, Luis E.
    Fowler, Nathan
    Nastoupil, Loretta
    Romaguera, Jorge E.
    Samaniego, Felipe
    Garg, Naveen
    Feng, Lei
    Wesson, Emily T.
    Ruben, Charnelle E.
    Stafford, Mildred D.
    Nieto, Yago
    Khouri, Issa F.
    Hosing, Chitra
    Horowitz, Sandra B.
    T-Kamble, Rammurti
    Fanale, Michelle A.
    HAEMATOLOGICA, 2018, 103 (09) : E416 - E418
  • [30] E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma: A phase I study
    Ohmachi, Ken
    Ando, Kiyoshi
    Ogura, Michinori
    Uchida, Toshiki
    Tobinai, Kensei
    Maruyama, Dai
    Namiki, Masayuki
    Nakanishi, Tadashi
    CANCER SCIENCE, 2018, 109 (03): : 794 - 802
12345